We found that the common up-regulated TF in both cell lines is JUN, a protoncogene that plays a dual role in regulation of tumor cell proliferation [61], and recently reported as candidate biomarker for personalized therapy in thymic epithelial tumors [62]. Here, TF is linked to neoplasm.